共 42 条
- [36] Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II 'proof-of-concept' iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network EUROPEAN JOURNAL OF CANCER, 2019, 117 : 121 - 130
- [37] Association between ocular findings and preventive therapy with onset of central nervous system involvement in patients with primary vitreoretinal lymphoma Graefe's Archive for Clinical and Experimental Ophthalmology, 2014, 252 : 687 - 693